Novo Nordisk Pins Hopes on CagriSema Data and Wegovy Combo Study to Reverse Stock’s Slide
Novo Nordisk unveils first Phase 3 CagriSema diabetes results at ADA, launches Wegovy combo trial with Veru, as…
Novo Nordisk at a Crossroads: Pipeline Hopes Meet Pricing Pressures Ahead of ADA and Medicare Shift
New semaglutide kidney data boosts pipeline confidence, but CVS formulary changes and discounted Medicare pricing pressure margins, sending…
Novo Nordisk Heads to New Orleans With Pipeline Hopes as Headwinds Multiply
Novo Nordisk’s Wegovy loses CVS exclusivity, faces product-liability lawsuits over blindness risk, but a new Medicare program opens…
European Lithium’s Austrian Setback and Greenland Hopes Collide Over A$24 Million Squeeze
Austrian court blocks key permit for European Lithium’s Wolfsberg project, delaying FID to late 2026. Company faces A$24M…
Indians’ hopes for German degrees dashed after Berlin restricts visas
Education Hundreds of IU students denied permits after school deemed to have broken rules The main entrance of…
Novo Nordisk’s CagriSema Data Locked as Pipeline Hopes Wrestle With a 50% Stock Wipeout
Novo Nordisk locks Phase 3 data for CagriSema vs Lilly’s Tirzepatid in diabetes, with shares at half their…